SIC
LUCD icon

SJS Investment Consulting’s Lucid Diagnostics LUCD Stock Holding History

SJS Investment Consulting’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$371 Buy
346
+341
+6,820% +$368 ﹤0.01% 2347
2026
Q1 		$6 Buy
+5
New +$6 ﹤0.01% 2447

Other funds holding LUCD

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.37B AUM 28.49% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.15B AUM 70.1% 1-Year Est. Return

SJS Investment Consulting's LUCD Position: Q2 2026 in Review

SJS Investment Consulting increased its Lucid Diagnostics (LUCD) stake by 6,820% in Q2 2026, buying an estimated $368 and bringing the position to 346 shares worth $371. The position accounts for ﹤0.01% of the portfolio, ranked #2347.

SJS Investment Consulting first reported a position in LUCD in Q1 2026 and has held it in 2 quarters since. 24 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • SJS Investment Consulting held 346 shares of Lucid Diagnostics worth $371 as of Q2 2026.
  • SJS Investment Consulting bought 341 Lucid Diagnostics shares in Q2 2026, an estimated $368.
  • Lucid Diagnostics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2347 holding.
  • SJS Investment Consulting first reported a position in Lucid Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • 24 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.